Axon (AXON) director Erika Nardini trims stake with 198-share sale

Rhea-AI Filing Summary

Axon Enterprise director Erika Nardini sold shares in an open-market trade. On March 17, 2026, she sold 198 shares of common stock at an average price of $506.579 per share. After this transaction, she directly holds 1,946 Axon common shares.

Insights

Equity analyst

Director Erika Nardini executed a small open-market sale, retaining a meaningful remaining share position.

Axon Enterprise board member Erika Nardini completed an open-market sale of 198 common shares at $506.579 per share on March 17, 2026. The filing characterizes this as a standard sale transaction in common stock.

Following the sale, Nardini directly owns 1,946 shares. No derivative positions are listed in this filing, suggesting the visible exposure is entirely in common stock. With only one sale transaction reported and no gifts, tax withholdings, or restructurings, this appears to be a straightforward, routine disposition.

The filing does not reference any Rule 10b5-1 trading plan or related entities, and the ownership is reported as direct. Future company filings may provide additional context if her board role or equity exposure changes over time.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nardini Erika

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		S		198	D	$506.579	1,946	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Erika Ayers by Isaiah Fields, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Axon (AXON) director Erika Nardini report?

Erika Nardini reported an open-market sale of Axon common stock. She sold 198 shares on March 17, 2026, at an average price of $506.579 per share, according to the Form 4 filing’s transaction details.

How many Axon (AXON) shares does Erika Nardini hold after this Form 4 sale?

After the reported sale, Erika Nardini directly holds 1,946 Axon common shares. The Form 4 shows this post-transaction balance and does not list any remaining derivative securities such as options or warrants for her position.

Was Erika Nardini’s Axon (AXON) transaction a buy or a sell?

The transaction was a sell. The Form 4 classifies it as an open-market sale of 198 Axon common shares, with a transaction code “S” and a transaction direction explicitly labeled as “sell” in the filing data.

At what price did Erika Nardini sell her Axon (AXON) shares?

She sold her Axon shares at an average price of $506.579 per share. This price is reported in the Form 4 as the transaction price per share for the 198 shares of common stock sold on March 17, 2026.

Does Erika Nardini’s Axon (AXON) Form 4 mention any derivative securities?

The Form 4 does not list any derivative securities for Erika Nardini. The derivativeSummary section is empty, and the only reported transaction involves non-derivative common stock, indicating no options or similar instruments in this particular filing.

Is Erika Nardini’s Axon (AXON) ownership reported as direct or indirect?

Her ownership is reported as direct in the Form 4. The transaction’s ownership code is “D,” and the nature of ownership field is empty, with no indication that the shares are held through a trust, LLC, or other indirect entity.